Apidaecin-1B

General Information


DRACP ID  DRACP02050

Peptide Name   Apidaecin-1B

Sequence  GNNRPVYIPQPRPPHPRL

Sequence Length  18

UniProt ID  P35581  Q06601  Q06602  B9UKC1  B9UKC0  B9UKB7  B9UKB5  B9UKB4  Q8WSY8 

PubChem CID  102602729 

Origin  Apis mellifera; Apis cerana cerana

Type  Native peptide

Classification

  

Active ACP Cancer targeted peptides Ribosome inhibitor



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
RAW 264.7 Mouse macrophage leukemia cell Leukemia LC50 =70 µM XTT assay 16 h 1
A431 Skin squamous cell carcinoma Carcinoma 34% Cytotoxicity=10 µM MTT assay 24 h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma Not active up to 10 µM MTT assay 24 h 1

Hemolytic Activity  Human erythrocytes: 1% Hemolysis=300 µm

Normal (non-cancerous) Cytotoxicity  Not available

Target  Ribosome

Affinity  Not available

Mechanism  Proline-rich antimicrobial peptides (PrAMPs) kill bacteria via a non-lytic mechanism in which they permeate through the outer membrane, utilize protein-mediated transport across the inner membrane, and target the ribosome to inhibit protein synthesis.

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02050

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C95H150N32O23

Absent amino acids  ACDEFKMSTW

Common amino acids  P

Mass  241182

Pl  12.2

Basic residues  4

Acidic residues  0

Hydrophobic residues  3

Net charge  4

Boman Index  -5356

Hydrophobicity  -144.44

Aliphatic Index  59.44

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  87.65

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31209863

Title  Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery

Doi 10.1002/bit.27092

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_1160

DRACP is developed by Dr.Zheng's team.